Cargando…

The Dosimetric Comparisons of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of Postoperative Radiotherapy in IIIA-N2 Stage Non-Small-Cell Lung Cancer Patients

Currently, studies about PORT in stage IIIA-N2 NSCLC patients in recent years have mostly adopted the conformal radiation therapy (CRT) technique, while other modern techniques such as intensity modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT, hereinafter referred to as AR...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yanqiu, Han, A'meng, Fu, Zhanzhao, Xu, Shufeng, Zhang, Zijian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442440/
https://www.ncbi.nlm.nih.gov/pubmed/31011583
http://dx.doi.org/10.1155/2019/8989241
_version_ 1783407711310839808
author Zhang, Yanqiu
Han, A'meng
Fu, Zhanzhao
Xu, Shufeng
Zhang, Zijian
author_facet Zhang, Yanqiu
Han, A'meng
Fu, Zhanzhao
Xu, Shufeng
Zhang, Zijian
author_sort Zhang, Yanqiu
collection PubMed
description Currently, studies about PORT in stage IIIA-N2 NSCLC patients in recent years have mostly adopted the conformal radiation therapy (CRT) technique, while other modern techniques such as intensity modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT, hereinafter referred to as ARC), helical tomotherapy (HT), and so forth are also developing quickly. In this paper, we intended to compare the dosimetric characteristics of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of PORT in stage IIIA-N2 NSCLC patients. Ten patients with stage IIIA-N2 completely resected NSCLC, whom were treated by PORT in the radiotherapy department of our hospital from January 1, 2017, to January 1, 2018, were randomly selected in this study. For each patient, the CRT plan, IMRT plan, ARC plan, CRT+IMRT plan, and CRT+ARC plan were designed separately on the same set of CT images. The isodose distribution and dose-volume histogram (DVH) of the five plans were compared to determine the dosimetric parameters of the targets, OAR (organs at risk), and the normal tissue (defined as body subtracted to PTV (planning target volume), B-P). No plan had absolute dosimetry advantages than any other plans. In clinical practice, the plans could be chosen according to their dosimetry characteristics.
format Online
Article
Text
id pubmed-6442440
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-64424402019-04-22 The Dosimetric Comparisons of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of Postoperative Radiotherapy in IIIA-N2 Stage Non-Small-Cell Lung Cancer Patients Zhang, Yanqiu Han, A'meng Fu, Zhanzhao Xu, Shufeng Zhang, Zijian Biomed Res Int Research Article Currently, studies about PORT in stage IIIA-N2 NSCLC patients in recent years have mostly adopted the conformal radiation therapy (CRT) technique, while other modern techniques such as intensity modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT, hereinafter referred to as ARC), helical tomotherapy (HT), and so forth are also developing quickly. In this paper, we intended to compare the dosimetric characteristics of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of PORT in stage IIIA-N2 NSCLC patients. Ten patients with stage IIIA-N2 completely resected NSCLC, whom were treated by PORT in the radiotherapy department of our hospital from January 1, 2017, to January 1, 2018, were randomly selected in this study. For each patient, the CRT plan, IMRT plan, ARC plan, CRT+IMRT plan, and CRT+ARC plan were designed separately on the same set of CT images. The isodose distribution and dose-volume histogram (DVH) of the five plans were compared to determine the dosimetric parameters of the targets, OAR (organs at risk), and the normal tissue (defined as body subtracted to PTV (planning target volume), B-P). No plan had absolute dosimetry advantages than any other plans. In clinical practice, the plans could be chosen according to their dosimetry characteristics. Hindawi 2019-03-18 /pmc/articles/PMC6442440/ /pubmed/31011583 http://dx.doi.org/10.1155/2019/8989241 Text en Copyright © 2019 Yanqiu Zhang et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Zhang, Yanqiu
Han, A'meng
Fu, Zhanzhao
Xu, Shufeng
Zhang, Zijian
The Dosimetric Comparisons of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of Postoperative Radiotherapy in IIIA-N2 Stage Non-Small-Cell Lung Cancer Patients
title The Dosimetric Comparisons of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of Postoperative Radiotherapy in IIIA-N2 Stage Non-Small-Cell Lung Cancer Patients
title_full The Dosimetric Comparisons of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of Postoperative Radiotherapy in IIIA-N2 Stage Non-Small-Cell Lung Cancer Patients
title_fullStr The Dosimetric Comparisons of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of Postoperative Radiotherapy in IIIA-N2 Stage Non-Small-Cell Lung Cancer Patients
title_full_unstemmed The Dosimetric Comparisons of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of Postoperative Radiotherapy in IIIA-N2 Stage Non-Small-Cell Lung Cancer Patients
title_short The Dosimetric Comparisons of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of Postoperative Radiotherapy in IIIA-N2 Stage Non-Small-Cell Lung Cancer Patients
title_sort dosimetric comparisons of crt, imrt, arc, crt+imrt, and crt+arc of postoperative radiotherapy in iiia-n2 stage non-small-cell lung cancer patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442440/
https://www.ncbi.nlm.nih.gov/pubmed/31011583
http://dx.doi.org/10.1155/2019/8989241
work_keys_str_mv AT zhangyanqiu thedosimetriccomparisonsofcrtimrtarccrtimrtandcrtarcofpostoperativeradiotherapyiniiian2stagenonsmallcelllungcancerpatients
AT hanameng thedosimetriccomparisonsofcrtimrtarccrtimrtandcrtarcofpostoperativeradiotherapyiniiian2stagenonsmallcelllungcancerpatients
AT fuzhanzhao thedosimetriccomparisonsofcrtimrtarccrtimrtandcrtarcofpostoperativeradiotherapyiniiian2stagenonsmallcelllungcancerpatients
AT xushufeng thedosimetriccomparisonsofcrtimrtarccrtimrtandcrtarcofpostoperativeradiotherapyiniiian2stagenonsmallcelllungcancerpatients
AT zhangzijian thedosimetriccomparisonsofcrtimrtarccrtimrtandcrtarcofpostoperativeradiotherapyiniiian2stagenonsmallcelllungcancerpatients
AT zhangyanqiu dosimetriccomparisonsofcrtimrtarccrtimrtandcrtarcofpostoperativeradiotherapyiniiian2stagenonsmallcelllungcancerpatients
AT hanameng dosimetriccomparisonsofcrtimrtarccrtimrtandcrtarcofpostoperativeradiotherapyiniiian2stagenonsmallcelllungcancerpatients
AT fuzhanzhao dosimetriccomparisonsofcrtimrtarccrtimrtandcrtarcofpostoperativeradiotherapyiniiian2stagenonsmallcelllungcancerpatients
AT xushufeng dosimetriccomparisonsofcrtimrtarccrtimrtandcrtarcofpostoperativeradiotherapyiniiian2stagenonsmallcelllungcancerpatients
AT zhangzijian dosimetriccomparisonsofcrtimrtarccrtimrtandcrtarcofpostoperativeradiotherapyiniiian2stagenonsmallcelllungcancerpatients